The largest database of trusted experimental protocols

9 protocols using annexin 5 binding

1

Annexin V-PI Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in a six-well plate and treated through various treatments to modulate MCL1 or p73 expression as they were in previous experiments. After the 24 or 48 h treatment, cells were collected through trypsin dissociation and washed twice with sterile DPBS. Cell number was counted on a BioRad Automated Cell Counter. After final wash, cells were pelleted at 1000×g for 10 min. The cell pellet was resuspended in 1× Annexin V binding buffer (BD Pharmingen, 556454) and 5 × 105 cells were transferred to a FACS tube containing 5 μL propidium iodide (PI) staining solution (BD Pharmingen, 51-66211E) and 5 μL FITC-Annexin V (BD Pharmingen, 556419). Cells were incubated for 15 min in the dark. FACS was collected on a BD LSRFortessa and analyzed using FlowJo v10. Compensation controls used for analysis include unstained cells and cells stained for each individual fluorophore (FITC-Annexin V and Cy5-PI). Gating strategy eliminated cell debris and doublets through forward and side scatter plots.
+ Open protocol
+ Expand
2

Annexin V Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in six-well plates and treated the next day with either the indicated amount of drug, vehicle (DMSO), or combination. Cells were incubated for two days, washed twice with ice-cold PBS, and resuspended in 1X annexin V binding buffer (10mM HEPES, 140mM NaCl, 2.5mM CaCl2; BD Biosciences). Surface exposure of phosphatidylserine was measured using APC-conjugated annexin V (BD Biosciences). 7-AAD (BD Biosciences) was used as a viability probe. Experiments were analyzed at 20,000 counts/sample using BD FACSVantage SE. Gatings were defined using untreated/unstained cells as appropriate.
+ Open protocol
+ Expand
3

Hematopoietic Stem Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies against Mac1, Gr1, B220, and CD3 (all from eBioscience) were used for peripheral blood analysis. Bone marrow lineage staining was carried out with biotinylated antibodies against Gr1, Ter119, B220, and CD3 (all from eBioscience). Bone marrow cells were also stained with antibodies against cKit, Sca1, CD16/32, CD34, FLT3, CD150, CD48, and IL7R (all from eBioscience). Flow cytometry and BrdU staining were carried out as previously described (70 ). Apoptosis was determined by AnnexinV binding (BD Biosciences). Flow cytometry was performed on FACSCalibur or LSRII flow cytometers (BD Biosciences) and analyzed with FlowJo software. Cell sorting was carried out on a FACSAria II (BD Biosciences).
+ Open protocol
+ Expand
4

MTT Viability, Apoptosis, and Cytotoxicity Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
[3–5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt] MTT cell viability assays were performed in 96-well dishes using Cell Titer 96 Aqueous One solution reagent (Promega, Madison, WI, USA) according to the manufacturer’s instructions. Data are expressed as a percentage of mock-infected cells analyzed in parallel.
Alternatively, cells cultured in 24-well plates (2 cm diameter) were treated as indicated in each figure legend (concentration of drug and time). Media and trypsinized adherent cells were centrifuged and analyzed for annexin V binding (BD Bioscience, San Jose, CA, USA) and propidium iodide (BD Bioscience) staining as described by the manufacturer. Cells were analyzed by flow cytometry using the CytoFLEX (Beckman Coulter, Brea, CA, USA) and 10,000 independent events were analyzed using CytExpert software (Beckman Coulter).
Cytotoxicity assays were performed in 96-well white plates (Corning, Corning, NY, USA) using CytoTox-Glo reagent (Promega) according to the manufacturer’s instructions. Data are expressed as a fold change of mock-infected cells analyzed in parallel. Functional caspase assays were performed in 96-well white plates (Corning) using Caspase-Glo 9, 8, or 3/7 assays (Promega) according to the manufacturer’s instructions. Data are expressed as a fold change of mock-infected cells analyzed in parallel.
+ Open protocol
+ Expand
5

Apoptosis Analysis of GANT61 and Cyclopamine Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (0.25 × 106) treated with GANT61 or Cyclopamine were incubated in 48-well plates in RPMI-1640 containing 10% FBS for 48 h. Cells were washed with Annexin V binding buffer and stained with 1 μg Annexin V FITC (BD Biosciences) for 20 min at 4°C in the dark. Cells were again washed with Annexin V binding buffer and then stained with 0.5 μg propidium iodide. Cells were immediately processed using a FACSCalibur (BD Biosciences) and data was analyzed using FlowJo software (FlowJo LLC).
+ Open protocol
+ Expand
6

Quantification of Apoptosis and Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Apoptosis was quantified using flow cytometry as detailed in our previous publication (37 (link)), for annexin V binding (BD Biosciences) and 7-aminoactinomycin D (7-AAD) expression (eBioscience). Caspase 3 activity was evaluated by immunoblotting. An MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] proliferation assay was carried out following the manufacturer’s instructions (Promega).
+ Open protocol
+ Expand
7

Annexin V/PI Flow Cytometry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells cultured in 24-well plates or 48-well plates were treated as indicated in each figure legend. Media and trypsinized adherent cells were centrifuged and analyzed for annexin V binding (BD Bioscience, San Jose, CA, USA) and propidium iodide (BD Bioscience) staining as described by the manufacturer. Cells were analyzed by flow cytometry using the CytoFLEX (Beckman Coulter, Brea, CA, USA) and 10,000 independent events were analyzed using CytExpert software (Beckman Coulter).
Alternatively, cytotoxicity assays were performed in 96-well white plates (Corning, Corning, NY, USA) using CytoTox-Glo reagent (Promega, Madison, WI, USA) according to the manufacturer’s instructions. Data are expressed as a fold change over mock-infected cells analyzed in parallel. Functional caspase assays were performed in 96-well white plates (Corning) using Caspase-Glo 9, 8, or 3/7 assays (Promega) according to the manufacturer’s instructions. Data are expressed as a fold change over mock-infected cells analyzed in parallel.
+ Open protocol
+ Expand
8

Neutrophil Apoptosis Assay with ST7 and G-CSF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected and assays were performed with the approval of the Institutional Review Board of the University of Massachusetts School of Medicine. Normal neutrophils were harvested from healthy volunteers, purified by sedimentation through 6% dextran, placed in culture in HBSS containing 1% human serum albumin serum, and incubated with ST7 at 200 μM, ST7-S at 50 μM, or G-CSF at 100 U/mL, at 37°C in a shaking water bath. Samples were analyzed after 24 and 43 hrs of exposure; apoptotic cell fraction was assayed by Annexin V binding (BD BioSciences; San Jose, CA) and a TUNEL assay using FITC-dUTP (Chemicon; Billerica, MA).
+ Open protocol
+ Expand
9

Melanoma Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
B16 mouse melanoma cell lines F0 (ATCC CRL-6322), F1 (ATCC CRL-6323), and F10 (ATCC CRL-6475) were purchased from the ATCC. Cell lines were expanded immediately after purchase and frozen in liquid nitrogen (lN2). Cells were routinely cultured in high glucose DMEM (Sigma-Aldrich) supplemented with 8% FBS, utilized within 10 passages after thawing from lN2, and regularly tested for Mycoplasma prior to injection into animals. Low metastatic potential B16F0 cells stably expressing EGFP or mCherry were generated by transfection of the EGFP-N1 vector or mCherry-C1 vector (Takara Bio) using Lipofectamine 2000 (Invitrogen) followed by selection in 1.2 mg/mL G418 (Life Technologies) and two rounds of fluorescenceactivated cell sorting to select stable pools of cells with high fluorescent protein expression (top 10%). In some experiments, B16F0 cells were maintained in normal B16F0 medium containing methotrexate (MTX; Cayman Chemicals) without or with z-vad-fmk (R&D Systems) or media conditioned by either MoDM or monocytes. After these treatments, apoptosis and cell death were quantified by flow cytometry using Annexin V binding (BD Biosciences) and DAPI uptake (Thermo Fisher Scientific).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!